For instance, inhibition of microglial enhancer of zeste homolog 2 (EZH2) demonstrates antitumor effects in pediatric diffuse midline gliomas, highlighting microglia as a promising therapeutic target [50]. The gene discussed is EZH2; the disease is diffuse midline glioma.